HIV Levels Before Treatment Can Predict This Immune System Indicator

Researchers may have finally answered a bedeviling chicken-or-egg question about the relationship between the persistence of HIV in the body during antiretroviral (ARV) treatment and the virus-related immune system activation and inflammation that also continues while people are on ARVs. This finding likely adds further weight to the urgency of diagnosing and treating HIV as…

Continue reading →

HIV Positive Smokers Who Quit Cut Their Risk of Numerous Cancers

Istock However, unlike HIV-negative quitters, their lung disease risk remains highly elevated for at least five years after kicking the habit. If people living with HIV who smoke quit their cigarette habit, they soon cut their risk of numerous cancers, aidsmap reports. However, unlike HIV-negative people who quit smoking, HIV-positive ex-smokers maintain a much higher,…

Continue reading →

New York’s strategy to end the HIV epidemic – an interesting perspective

            At the recent Conference on Retroviruses and Opportunistic Infections 2017 (CROI) held in Seattle Washington in March there was a range of interesting and informative presentations on different aspects of treatment, living with HIV, ending HIV and a range of other research findings. The following is a report from…

Continue reading →